cached image

Gabriella Gobbi, MD PhD - Publications

Psychiatry McGill University, Montreal, QC, Canada 
Mental Illness and Addiction, Neurosciences

99 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Inserra A, De Gregorio D, Rezai T, Lopez-Canul MG, Comai S, Gobbi G. Lysergic acid diethylamide differentially modulates the reticular thalamus, mediodorsal thalamus, and infralimbic prefrontal cortex: An in vivo electrophysiology study in male mice. Journal of Psychopharmacology (Oxford, England). 269881121991569. PMID 33645311 DOI: 10.1177/0269881121991569  0.8
2021 De Gregorio D, Popic J, Enns JP, Inserra A, Skalecka A, Markopoulos A, Posa L, Lopez-Canul M, Qianzi H, Lafferty CK, Britt JP, Comai S, Aguilar-Valles A, Sonenberg N, Gobbi G. Lysergic acid diethylamide (LSD) promotes social behavior through mTORC1 in the excitatory neurotransmission. Proceedings of the National Academy of Sciences of the United States of America. 118. PMID 33495318 DOI: 10.1073/pnas.2020705118  0.8
2021 Angeloni D, Gobbi G, Comai S. Franco Fraschini, MD, PhD (1932-2020). Journal of Pineal Research. 70: e12688. PMID 33405279 DOI: 10.1111/Jpi.12688  0.52
2021 Inserra A, De Gregorio D, Gobbi G. Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms. Pharmacological Reviews. 73: 202-277. PMID 33328244 DOI: 10.1124/pharmrev.120.000056  0.8
2020 Aguilar-Valles A, De Gregorio D, Matta-Camacho E, Eslamizade MJ, Khlaifia A, Skaleka A, Lopez-Canul M, Torres-Berrio A, Bermudez S, Rurak GM, Simard S, Salmaso N, Gobbi G, Lacaille JC, Sonenberg N. Antidepressant actions of ketamine engage cell-specific translation via eIF4E. Nature. PMID 33328636 DOI: 10.1038/s41586-020-03047-0  0.8
2020 De Gregorio D, Aguilar-Valles A, Preller KH, Heifets BD, Hibicke M, Mitchell J, Gobbi G. Hallucinogens in Mental Health: Preclinical and Clinical Studies on LSD, Psilocybin, MDMA, and Ketamine. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 33257322 DOI: 10.1523/JNEUROSCI.1659-20.2020  0.8
2020 De Gregorio D, Dean Conway J, Canul ML, Posa L, Bambico FR, Gobbi G. Effects of chronic exposure to low doses of Δ9- tetrahydrocannabinol in adolescence and adulthood on serotonin/norepinephrine neurotransmission and emotional behaviors. The International Journal of Neuropsychopharmacology. PMID 32725198 DOI: 10.1093/Ijnp/Pyaa058  0.96
2020 Comai S, De Gregorio D, Posa L, Ochoa-Sanchez R, Bedini A, Gobbi G. Dysfunction of serotonergic activity and emotional responses across the light-dark cycle in mice lacking MT receptors. Journal of Pineal Research. e12653. PMID 32239546 DOI: 10.1111/Jpi.12653  0.8
2019 Bambico FR, Li Z, Creed M, De Gregorio D, Diwan M, Li J, McNeill S, Gobbi G, Raymond R, Nobrega JN. A Key Role for Prefrontocortical Small Conductance Calcium-Activated Potassium Channels in Stress Adaptation and Rapid Antidepressant Response. Cerebral Cortex (New York, N.Y. : 1991). PMID 31504265 DOI: 10.1093/Cercor/Bhz187  0.96
2019 López-Canul M, Min SH, Posa L, De Gregorio D, Bedini A, Spadoni G, Gobbi G, Comai S. Melatonin MT and MT Receptors Exhibit Distinct Effects in the Modulation of Body Temperature across the Light/Dark Cycle. International Journal of Molecular Sciences. 20. PMID 31108968 DOI: 10.3390/Ijms20102452  0.8
2019 Comai S, Lopez-Canul M, De Gregorio D, Posner A, Ettaoussi M, Guarnieri F, Gobbi G. Melatonin MT receptor as a novel target in neuropsychopharmacology: MT ligands, pathophysiological and therapeutic implications and perspectives. Pharmacological Research. PMID 31029764 DOI: 10.1016/J.Phrs.2019.04.015  0.8
2019 Gobbi G, Comai S. Differential Function of Melatonin MT and MT Receptors in REM and NREM Sleep. Frontiers in Endocrinology. 10: 87. PMID 30881340 DOI: 10.3389/Fendo.2019.00087  0.52
2019 Comai S, Bertazzo A, Vachon J, Daigle M, Toupin J, Côté G, Gobbi G. Trace elements among a sample of prisoners with mental and personality disorders and aggression: correlation with impulsivity and ADHD indices. Journal of Trace Elements in Medicine and Biology : Organ of the Society For Minerals and Trace Elements (Gms). 51: 123-129. PMID 30466921 DOI: 10.1016/J.Jtemb.2018.10.008  0.52
2018 Gobbi G, Comai S. Sleep well. Untangling the role of melatonin MT1 and MT2 receptor in sleep. Journal of Pineal Research. e12544. PMID 30586215 DOI: 10.1111/Jpi.12544  0.52
2018 De Gregorio D, Enns JP, Nuñez NA, Posa L, Gobbi G. d-Lysergic acid diethylamide, psilocybin, and other classic hallucinogens: Mechanism of action and potential therapeutic applications in mood disorders. Progress in Brain Research. 242: 69-96. PMID 30471683 DOI: 10.1016/Bs.Pbr.2018.07.008  0.8
2018 De Gregorio D, Manchia M, Carpiniello B, Valtorta F, Nobile M, Gobbi G, Comai S. Role of palmitoylethanolamide (PEA) in depression: Translational evidence. Journal of Affective Disorders. PMID 30391203 DOI: 10.1016/J.Jad.2018.10.117  0.8
2018 De Gregorio D, McLaughlin RJ, Posa L, Ochoa-Sanchez R, Enns J, Lopez-Canul M, Aboud M, Maione S, Comai S, Gobbi G. Cannabidiol modulates serotonergic transmission and prevents allodynia and anxiety-like behavior in a model of neuropathic pain. Pain. PMID 30157131 DOI: 10.1097/J.Pain.0000000000001386  0.96
2018 Aguilar-Valles A, Haji N, De Gregorio D, Matta-Camacho E, Eslamizade MJ, Popic J, Sharma V, Cao R, Rummel C, Tanti A, Wiebe S, Nuñez N, Comai S, Nadon R, Luheshi G, ... ... Gobbi G, et al. Translational control of depression-like behavior via phosphorylation of eukaryotic translation initiation factor 4E. Nature Communications. 9: 2459. PMID 29941989 DOI: 10.1038/S41467-018-04883-5  0.8
2018 Bambico FR, Comai S, Hasan MSN, Conway JD, Darvish-Gane S, Hamani C, Gobbi G, Nobrega JN. High frequency stimulation of the anterior vermis modulates behavioural response to chronic stress: Involvement of the prefrontal cortex and dorsal raphe? Neurobiology of Disease. PMID 29727711 DOI: 10.1016/J.Nbd.2018.03.011  0.96
2018 Messaoud A, Rym M, Douki W, Neffati F, Najjar MF, Gobbi G, Valtorta F, Gaha L, Comai S. Reduced peripheral availability of tryptophan and increased activation of the kynurenine pathway and cortisol correlate with major depression and suicide. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 1-28. PMID 29683396 DOI: 10.1080/15622975.2018.1468031  0.52
2018 Nuñez NA, Comai S, Dumitrescu E, Ghabrash MF, Tabaka J, Saint-Laurent M, Vida S, Kolivakis T, Fielding A, Low N, Cervantes P, Booij L, Gobbi G. Psychopathological and sociodemographic features in treatment-resistant unipolar depression versus bipolar depression: a comparative study. Bmc Psychiatry. 18: 68. PMID 29548306 DOI: 10.1186/S12888-018-1641-Y  0.68
2018 Atkin T, Comai S, Gobbi G. Drugs for Insomnia beyond Benzodiazepines: Pharmacology, Clinical Applications, and Discovery. Pharmacological Reviews. 70: 197-245. PMID 29487083 DOI: 10.1124/Pr.117.014381  0.52
2017 Gobbi G, Ghabrash MF, Nuñez N, Tabaka J, Di Sante J, Saint-Laurent M, Vida S, Kolivakis T, Low N, Cervantes P, Booij L, Comai S. Antidepressant combination versus antidepressants plus second-generation antipsychotic augmentation in treatment-resistant unipolar depression. International Clinical Psychopharmacology. PMID 28906325 DOI: 10.1097/Yic.0000000000000196  0.52
2017 Posa L, De Gregorio D, Gobbi G, Comai S. Targeting melatonin MT2 receptors: A novel pharmacological avenue for inflammatory and neuropathic pain. Current Medicinal Chemistry. PMID 28183259 DOI: 10.2174/0929867324666170209104926  0.8
2017 Nuñez NA, Gobbi G. Lurasidone and Mood Stabilizers in Treatment-Resistant Unipolar Depression: A Case Report Study. Journal of Clinical Psychopharmacology. PMID 28129315 DOI: 10.1097/Jcp.0000000000000664  0.68
2016 De Gregorio D, Comai S, Posa L, Gobbi G. d-Lysergic Acid Diethylamide (LSD) as a Model of Psychosis: Mechanism of Action and Pharmacology. International Journal of Molecular Sciences. 17. PMID 27886063 DOI: 10.3390/Ijms17111953  0.8
2016 De Gregorio D, Posa L, Ochoa-Sanchez R, McLaughlin R, Maione S, Comai S, Gobbi G. The hallucinogen d-lysergic diethylamide (LSD) decreases dopamine firing activity through 5-HT1A, D2 and TAAR1 receptors. Pharmacological Research. 113: 81-91. PMID 27544651 DOI: 10.1016/J.Phrs.2016.08.022  0.8
2016 Brodie MJ, Besag F, Ettinger AB, Mula M, Gobbi G, Comai S, Aldenkamp AP, Steinhoff BJ. Epilepsy, Antiepileptic Drugs, and Aggression: An Evidence-Based Review. Pharmacological Reviews. 68: 563-602. PMID 27255267 DOI: 10.1124/Pr.115.012021  1
2016 Comai S, Bertazzo A, Vachon J, Daigle M, Toupin J, Côté G, Turecki G, Gobbi G. Tryptophan via serotonin/kynurenine pathways abnormalities in a large cohort of aggressive inmates: Markers for aggression. Progress in Neuro-Psychopharmacology & Biological Psychiatry. PMID 27117820 DOI: 10.1016/J.Pnpbp.2016.04.012  1
2015 Bambico FR, Duranti A, Nobrega JN, Gobbi G. The fatty acid amide hydrolase inhibitor URB597 modulates serotonin-dependent emotional behaviour, and serotonin1A and serotonin2A/C activity in the hippocampus. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 26747370 DOI: 10.1016/J.Euroneuro.2015.12.027  1
2015 Gobbi G, Low NC, Dugas E, Sylvestre MP, Contreras G, O'loughlin J. Short-Term Natural Course of Depressive Symptoms and Family-Related Stress in Adolescents After Separation From Father. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 60: 417-426. PMID 26720187 DOI: 10.1177/070674371506001002  1
2015 Ghabrash MF, Comai S, Tabaka J, Saint-Laurent M, Booij L, Gobbi G. Valproate augmentation in a subgroup of patients with treatment-resistant unipolar depression. The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry. 1-6. PMID 26444701 DOI: 10.3109/15622975.2015.1073856  1
2015 López-Canul M, Comai S, Domínguez-López S, Granados-Soto V, Gobbi G. Antinociceptive properties of selective MT2 melatonin receptor partial agonists. European Journal of Pharmacology. 764: 424-32. PMID 26162699 DOI: 10.1016/J.Ejphar.2015.07.010  1
2015 Lacoste B, Angeloni D, Dominguez-Lopez S, Calderoni S, Mauro A, Fraschini F, Descarries L, Gobbi G. Anatomical and cellular localization of melatonin MT1 and MT2 receptors in the adult rat brain. Journal of Pineal Research. 58: 397-417. PMID 25726952 DOI: 10.1111/Jpi.12224  1
2015 Comai S, Ochoa-Sanchez R, Dominguez-Lopez S, Bambico FR, Gobbi G. Melancholic-Like behaviors and circadian neurobiological abnormalities in melatonin MT1 receptor knockout mice. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 18. PMID 25638817 DOI: 10.1093/Ijnp/Pyu075  0.96
2015 Lopez-Canul M, Palazzo E, Dominguez-Lopez S, Luongo L, Lacoste B, Comai S, Angeloni D, Fraschini F, Boccella S, Spadoni G, Bedini A, Tarzia G, Maione S, Granados-Soto V, Gobbi G. Selective melatonin MT2 receptor ligands relieve neuropathic pain through modulation of brainstem descending antinociceptive pathways. Pain. 156: 305-17. PMID 25599452 DOI: 10.1097/01.J.Pain.0000460311.71572.5F  1
2015 Checknita D, Maussion G, Labonté B, Comai S, Tremblay RE, Vitaro F, Turecki N, Bertazzo A, Gobbi G, Côté G, Turecki G. Monoamine oxidase A gene promoter methylation and transcriptional downregulation in an offender population with antisocial personality disorder. The British Journal of Psychiatry : the Journal of Mental Science. 206: 216-22. PMID 25497297 DOI: 10.1192/Bjp.Bp.114.144964  1
2015 Bambico FR, Lacoste B, Hattan PR, Gobbi G. Father absence in the monogamous california mouse impairs social behavior and modifies dopamine and glutamate synapses in the medial prefrontal cortex. Cerebral Cortex (New York, N.Y. : 1991). 25: 1163-75. PMID 24304503 DOI: 10.1093/Cercor/Bht310  1
2014 Horn M, Potvin S, Allaire JF, Côté G, Gobbi G, Benkirane K, Vachon J, Dumais A. Male inmate profiles and their biological correlates. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 59: 441-9. PMID 25161069 DOI: 10.1177/070674371405900807  1
2014 Domínguez-López S, Howell RD, López-Canúl MG, Leyton M, Gobbi G. Electrophysiological characterization of dopamine neuronal activity in the ventral tegmental area across the light-dark cycle. Synapse (New York, N.Y.). 68: 454-67. PMID 24955825 DOI: 10.1002/Syn.21757  1
2014 Gobbi G. Quetiapine in postpartum psychosis. Journal of Clinical Psychopharmacology. 34: 744-5. PMID 24943395 DOI: 10.1097/Jcp.0000000000000162  1
2014 Gobbi G, Comai S, Debonnel G. Effects of quetiapine and olanzapine in patients with psychosis and violent behavior: a pilot randomized, open-label, comparative study. Neuropsychiatric Disease and Treatment. 10: 757-65. PMID 24855361 DOI: 10.2147/Ndt.S59968  1
2014 Rainer Q, Speziali S, Rubino T, Dominguez-Lopez S, Bambico FR, Gobbi G, Parolaro D. Chronic nandrolone decanoate exposure during adolescence affects emotional behavior and monoaminergic neurotransmission in adulthood. Neuropharmacology. 83: 79-88. PMID 24721625 DOI: 10.1016/J.Neuropharm.2014.03.015  1
2014 Ochoa-Sanchez R, Comai S, Spadoni G, Bedini A, Tarzia G, Gobbi G. Melatonin, selective and non-selective MT1/MT2 receptors agonists: differential effects on the 24-h vigilance states. Neuroscience Letters. 561: 156-61. PMID 24406151 DOI: 10.1016/J.Neulet.2013.12.069  1
2014 Comai S, Gobbi G. Unveiling the role of melatonin MT2 receptors in sleep, anxiety and other neuropsychiatric diseases: a novel target in psychopharmacology. Journal of Psychiatry & Neuroscience : Jpn. 39: 6-21. PMID 23971978 DOI: 10.1503/Jpn.130009  1
2013 Comai S, Ochoa-Sanchez R, Gobbi G. Sleep-wake characterization of double MT₁/MTâ‚‚ receptor knockout mice and comparison with MT₁ and MTâ‚‚ receptor knockout mice. Behavioural Brain Research. 243: 231-8. PMID 23333399 DOI: 10.1016/J.Bbr.2013.01.008  1
2013 Gobbi G. Modulation of serotonin firing activity through CB1 agonists and FAAH inhibitors Endocannabinoid Regulation of Monoamines in Psychiatric and Neurological Disorders. 255-275. DOI: 10.1007/978-1-4614-7940-6_12  1
2012 Domínguez-López S, Howell R, Gobbi G. Characterization of serotonin neurotransmission in knockout mice: implications for major depression. Reviews in the Neurosciences. 23: 429-43. PMID 23089640 DOI: 10.1515/Revneuro-2012-0044  1
2012 Ochoa-Sanchez R, Rainer Q, Comai S, Spadoni G, Bedini A, Rivara S, Fraschini F, Mor M, Tarzia G, Gobbi G. Anxiolytic effects of the melatonin MT(2) receptor partial agonist UCM765: comparison with melatonin and diazepam. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 39: 318-25. PMID 22789661 DOI: 10.1016/J.Pnpbp.2012.07.003  1
2012 Morales-Medina JC, Dominguez-Lopez S, Gobbi G, Beck-Sickinger AG, Quirion R. The selective neuropeptide Y Y5 agonist [cPP(1-7),NPY(19-23),Ala31,Aib32,Gln34]hPP differently modulates emotional processes and body weight in the rat. Behavioural Brain Research. 233: 298-304. PMID 22613731 DOI: 10.1016/J.Bbr.2012.05.015  1
2012 Bambico FR, Hattan PR, Garant JP, Gobbi G. Effect of delta-9-tetrahydrocannabinol on behavioral despair and on pre- and postsynaptic serotonergic transmission. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 38: 88-96. PMID 22386778 DOI: 10.1016/J.Pnpbp.2012.02.006  1
2012 Comai S, Tau M, Pavlovic Z, Gobbi G. The psychopharmacology of aggressive behavior: a translational approach: part 2: clinical studies using atypical antipsychotics, anticonvulsants, and lithium. Journal of Clinical Psychopharmacology. 32: 237-60. PMID 22367663 DOI: 10.1097/Jcp.0B013E31824929D6  1
2012 McLaughlin RJ, Hill MN, Bambico FR, Stuhr KL, Gobbi G, Hillard CJ, Gorzalka BB. Prefrontal cortical anandamide signaling coordinates coping responses to stress through a serotonergic pathway. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 22: 664-71. PMID 22325231 DOI: 10.1016/J.Euroneuro.2012.01.004  1
2012 Comai S, Tau M, Gobbi G. The psychopharmacology of aggressive behavior: a translational approach: part 1: neurobiology. Journal of Clinical Psychopharmacology. 32: 83-94. PMID 22198449 DOI: 10.1097/Jcp.0B013E31823F8770  1
2012 Labonte B, McLaughlin RJ, Dominguez-Lopez S, Bambico FR, Lucchino I, Ochoa-Sanchez R, Leyton M, Gobbi G. Adolescent amphetamine exposure elicits dose-specific effects on monoaminergic neurotransmission and behaviour in adulthood. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 15: 1319-30. PMID 22053980 DOI: 10.1017/S1461145711001544  1
2012 McLaughlin RJ, Gobbi G. Cannabinoids and emotionality: a neuroanatomical perspective. Neuroscience. 204: 134-44. PMID 21827834 DOI: 10.1016/J.Neuroscience.2011.07.052  1
2012 Domínguez-López S, Mahar I, Bambico FR, Labonté B, Ochoa-Sánchez R, Leyton M, Gobbi G. Short-term effects of melatonin and pinealectomy on serotonergic neuronal activity across the light-dark cycle. Journal of Psychopharmacology (Oxford, England). 26: 830-44. PMID 21730015 DOI: 10.1177/0269881111408460  1
2012 Dumais A, Potvin S, Joyal C, Allaire JF, Stip E, Lesage A, Gobbi G, Côté G. Schizophrenia and serious violence: A clinical-profile analysis incorporating impulsivity and substance-use disorders | Esquizofrenia y violencia grave: un análisis del perfil clínico que incorpora la impulsividad y los trastornos de consumo de sustancias Psiquiatria Biologica. 19: 65-68. DOI: 10.1016/J.Psiq.2012.06.003  1
2011 Ochoa-Sanchez R, Comai S, Lacoste B, Bambico FR, Dominguez-Lopez S, Spadoni G, Rivara S, Bedini A, Angeloni D, Fraschini F, Mor M, Tarzia G, Descarries L, Gobbi G. Promotion of non-rapid eye movement sleep and activation of reticular thalamic neurons by a novel MT2 melatonin receptor ligand. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 31: 18439-52. PMID 22171046 DOI: 10.1523/Jneurosci.2676-11.2011  1
2011 Dumais A, Potvin S, Joyal C, Allaire JF, Stip E, Lesage A, Gobbi G, Côté G. Schizophrenia and serious violence: a clinical-profile analysis incorporating impulsivity and substance-use disorders. Schizophrenia Research. 130: 234-7. PMID 21441016 DOI: 10.1016/J.Schres.2011.02.024  1
2011 Cassano T, Gaetani S, Macheda T, Laconca L, Romano A, Morgese MG, Cimmino CS, Chiarotti F, Bambico FR, Gobbi G, Cuomo V, Piomelli D. Evaluation of the emotional phenotype and serotonergic neurotransmission of fatty acid amide hydrolase-deficient mice. Psychopharmacology. 214: 465-76. PMID 21042794 DOI: 10.1007/S00213-010-2051-0  1
2010 Bambico FR, Cassano T, Dominguez-Lopez S, Katz N, Walker CD, Piomelli D, Gobbi G. Genetic deletion of fatty acid amide hydrolase alters emotional behavior and serotonergic transmission in the dorsal raphe, prefrontal cortex, and hippocampus. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 2083-100. PMID 20571484 DOI: 10.1038/Npp.2010.80  1
2010 Mazella J, Pétrault O, Lucas G, Deval E, Béraud-Dufour S, Gandin C, El-Yacoubi M, Widmann C, Guyon A, Chevet E, Taouji S, Conductier G, Corinus A, Coppola T, Gobbi G, et al. Spadin, a sortilin-derived peptide, targeting rodent TREK-1 channels: a new concept in the antidepressant drug design. Plos Biology. 8: e1000355. PMID 20405001 DOI: 10.1371/Journal.Pbio.1000355  1
2010 Bambico FR, Nguyen NT, Katz N, Gobbi G. Chronic exposure to cannabinoids during adolescence but not during adulthood impairs emotional behaviour and monoaminergic neurotransmission. Neurobiology of Disease. 37: 641-55. PMID 19969082 DOI: 10.1016/J.Nbd.2009.11.020  1
2010 Peccianti M, Seyed Sadr M, Sabau C, Sharma G, Blanchard F, Razzari L, Maret D, Seyed Sadr E, Alshami J, Siu V, Gobbi G, Ozaki T, Del Maestro R, Morandott R. Evaluation of the electromagnetic hazard of intense thz pulses on neural cells Optics Infobase Conference Papers 1
2009 Hill MN, Hillard CJ, Bambico FR, Patel S, Gorzalka BB, Gobbi G. The therapeutic potential of the endocannabinoid system for the development of a novel class of antidepressants. Trends in Pharmacological Sciences. 30: 484-93. PMID 19732971 DOI: 10.1016/J.Tips.2009.06.006  1
2009 Rivara S, Vacondio F, Fioni A, Silva C, Carmi C, Mor M, Lucini V, Pannacci M, Caronno A, Scaglione F, Gobbi G, Spadoni G, Bedini A, Orlando P, Lucarini S, et al. N-(Anilinoethyl)amides: design and synthesis of metabolically stable, selective melatonin receptor ligands. Chemmedchem. 4: 1746-55. PMID 19728346 DOI: 10.1002/Cmdc.200900240  1
2009 Labonte B, Bambico FR, Gobbi G. Potentiation of excitatory serotonergic responses by MK-801 in the medial prefrontal cortex. Naunyn-Schmiedeberg's Archives of Pharmacology. 380: 383-97. PMID 19727675 DOI: 10.1007/S00210-009-0446-4  1
2009 Bambico FR, Duranti A, Tontini A, Tarzia G, Gobbi G. Endocannabinoids in the treatment of mood disorders: evidence from animal models. Current Pharmaceutical Design. 15: 1623-46. PMID 19442178 DOI: 10.2174/138161209788168029  1
2009 Blier P, Gobbi G, Turcotte JE, de Montigny C, Boucher N, Hébert C, Debonnel G. Mirtazapine and paroxetine in major depression: a comparison of monotherapy versus their combination from treatment initiation. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 19: 457-65. PMID 19345072 DOI: 10.1016/J.Euroneuro.2009.01.015  1
2009 Cassano T, Gaetani S, Morgese MG, Macheda T, Laconca L, Dipasquale P, Taltavull J, Shippenberg TS, Cuomo V, Gobbi G. Monoaminergic changes in locus coeruleus and dorsal raphe nucleus following noradrenaline depletion. Neurochemical Research. 34: 1417-26. PMID 19229609 DOI: 10.1007/S11064-009-9928-5  1
2009 Bambico FR, Nguyen NT, Gobbi G. Decline in serotonergic firing activity and desensitization of 5-HT1A autoreceptors after chronic unpredictable stress. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 19: 215-28. PMID 19147333 DOI: 10.1016/J.Euroneuro.2008.11.005  1
2008 Di Marzo V, Gobbi G, Szallasi A. Brain TRPV1: a depressing TR(i)P down memory lane? Trends in Pharmacological Sciences. 29: 594-600. PMID 18947889 DOI: 10.1016/J.Tips.2008.09.004  1
2008 Bambico FR, Gobbi G. The cannabinoid CB1 receptor and the endocannabinoid anandamide: possible antidepressant targets. Expert Opinion On Therapeutic Targets. 12: 1347-66. PMID 18851692 DOI: 10.1517/14728222.12.11.1347  1
2008 Berney A, Nishikawa M, Benkelfat C, Debonnel G, Gobbi G, Diksic M. An index of 5-HT synthesis changes during early antidepressant treatment: alpha-[11C]methyl-L-tryptophan PET study. Neurochemistry International. 52: 701-8. PMID 17928105 DOI: 10.1016/J.Neuint.2007.08.021  1
2007 Rivara S, Lodola A, Mor M, Bedini A, Spadoni G, Lucini V, Pannacci M, Fraschini F, Scaglione F, Sanchez RO, Gobbi G, Tarzia G. N-(substituted-anilinoethyl)amides: design, synthesis, and pharmacological characterization of a new class of melatonin receptor ligands. Journal of Medicinal Chemistry. 50: 6618-26. PMID 18052314 DOI: 10.1021/Jm700957J  1
2007 Bambico FR, Katz N, Debonnel G, Gobbi G. Cannabinoids elicit antidepressant-like behavior and activate serotonergic neurons through the medial prefrontal cortex. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 11700-11. PMID 17959812 DOI: 10.1523/Jneurosci.1636-07.2007  1
2007 Gobbi G, Cassano T, Radja F, Morgese MG, Cuomo V, Santarelli L, Hen R, Blier P. Neurokinin 1 receptor antagonism requires norepinephrine to increase serotonin function. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 17: 328-38. PMID 16950604 DOI: 10.1016/J.Euroneuro.2006.07.004  1
2006 Jansen AC, Sancak O, D'Agostino MD, Badhwar A, Roberts P, Gobbi G, Wilkinson R, Melanson D, Tampieri D, Koenekoop R, Gans M, Maat-Kievit A, Goedbloed M, van den Ouweland AM, Nellist M, et al. Unusually mild tuberous sclerosis phenotype is associated with TSC2 R905Q mutation. Annals of Neurology. 60: 528-39. PMID 17120248 DOI: 10.1002/Ana.21037  1
2006 Gobbi G, Gaudreau PO, Leblanc N. Efficacy of topiramate, valproate, and their combination on aggression/agitation behavior in patients with psychosis. Journal of Clinical Psychopharmacology. 26: 467-73. PMID 16974186 DOI: 10.1097/01.Jcp.0000237945.35022.45  1
2006 Heurteaux C, Lucas G, Guy N, El Yacoubi M, Thümmler S, Peng XD, Noble F, Blondeau N, Widmann C, Borsotto M, Gobbi G, Vaugeois JM, Debonnel G, Lazdunski M. Deletion of the background potassium channel TREK-1 results in a depression-resistant phenotype. Nature Neuroscience. 9: 1134-41. PMID 16906152 DOI: 10.1038/Nn1749  1
2006 Gobbi G, Janiri L. Sodium- and magnesium-valproate in vivo modulate glutamatergic and GABAergic synapses in the medial prefrontal cortex. Psychopharmacology. 185: 255-62. PMID 16496131 DOI: 10.1007/S00213-006-0317-3  1
2005 Gobbi G, Bambico FR, Mangieri R, Bortolato M, Campolongo P, Solinas M, Cassano T, Morgese MG, Debonnel G, Duranti A, Tontini A, Tarzia G, Mor M, Trezza V, Goldberg SR, et al. Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis. Proceedings of the National Academy of Sciences of the United States of America. 102: 18620-5. PMID 16352709 DOI: 10.1073/Pnas.0509591102  1
2005 Gobbi G. Serotonin firing activity as a marker for mood disorders: lessons from knockout mice. International Review of Neurobiology. 65: 249-72. PMID 16140059 DOI: 10.1016/S0074-7742(04)65009-4  1
2005 Gobbi G, Blier P. Effect of neurokinin-1 receptor antagonists on serotoninergic, noradrenergic and hippocampal neurons: comparison with antidepressant drugs. Peptides. 26: 1383-93. PMID 16042978 DOI: 10.1016/J.Peptides.2005.03.032  1
2004 Blier P, Gobbi G, Haddjeri N, Santarelli L, Mathew G, Hen R. Impact of substance P receptor antagonism on the serotonin and norepinephrine systems: relevance to the antidepressant/anxiolytic response. Journal of Psychiatry & Neuroscience : Jpn. 29: 208-18. PMID 15173897  1
2003 Gobbi G, Debonnel G. What is a recommended treatment for aggression in a patient with schizophrenia? Journal of Psychiatry & Neuroscience : Jpn. 28: 320. PMID 12921225  1
2003 Gobbi G, Slater S, Boucher N, Debonnel G, Blier P. Neurochemical and psychotropic effects of bupropion in healthy male subjects. Journal of Clinical Psychopharmacology. 23: 233-9. PMID 12826985 DOI: 10.1097/01.Jcp.0000084023.22282.03  1
2002 Santarelli L, Gobbi G, Blier P, Hen R. Behavioral and physiologic effects of genetic or pharmacologic inactivation of the substance P receptor (NK1). The Journal of Clinical Psychiatry. 63: 11-7. PMID 12562138  1
2001 Gobbi G, Muntoni AL, Gessa GL, Diana M. Clonidine fails to modify dopaminergic neuronal activity during morphine withdrawal. Psychopharmacology. 158: 1-6. PMID 11685378 DOI: 10.1007/S002130100832  1
2001 Gobbi G, Pulvirenti L. Long-term treatment with clozapine in an adult with autistic disorder accompanied by aggressive behaviour [2] Journal of Psychiatry and Neuroscience. 26: 340-341. PMID 11590976  1
2001 Gobbi G, Murphy DL, Lesch K, Blier P. Modifications of the serotonergic system in mice lacking serotonin transporters: an in vivo electrophysiological study. The Journal of Pharmacology and Experimental Therapeutics. 296: 987-95. PMID 11181933  1
2001 Santarelli L, Gobbi G, Debs PC, Sibille ET, Blier P, Hen R, Heath MJ. Genetic and pharmacological disruption of neurokinin 1 receptor function decreases anxiety-related behaviors and increases serotonergic function. Proceedings of the National Academy of Sciences of the United States of America. 98: 1912-7. PMID 11172050 DOI: 10.1073/Pnas.98.4.1912  1
1999 Gobbi G, Janiri L. Clozapine blocks dopamine, 5-HT2 and 5-HT3 responses in the medial prefrontal cortex: An in vivo microiontophoretic study European Neuropsychopharmacology. 10: 43-49. PMID 10647096 DOI: 10.1016/S0924-977X(99)00055-3  1
1996 Janiri L, Gobbi G, Mannelli P, Pozzi G, Serretti A, Tempesta E. Effects of fluoxetine at antidepressant doses on short-term outcome of detoxified alcoholics International Clinical Psychopharmacology. 11: 109-117. PMID 8803648 DOI: 10.1097/00004850-199606000-00005  1
1995 Santarelli M, Granato A, Sbriccoli A, Gobbi G, Janiri L, Minciacchi D. Alterations of the thalamo-cortical system in rats prenatally exposed to ethanol are prevented by concurrent administration of acetyl- l-carnitine Brain Research. 698: 241-247. PMID 8581491 DOI: 10.1016/0006-8993(95)00997-5  1
1994 Janiri L, Gobbi G, Persico AM, Santarelli M, Minciacchi D, Tempesta E. Alterations of neocortical neuronal responses to acetylcholine and gaba in rats born to alcohol-dependent mothers Alcohol and Alcoholism. 29: 611-619. PMID 7811346 DOI: 10.1093/Oxfordjournals.Alcalc.A045591  1
1993 De Marinis L, Mancini A, Fiumara C, Conte G, Iacona T, Ianiri L, Zeppetelli E, Gobbi G, Tempesta E. Growth hormone response to growth hormone-releasing hormone in early abstinent alcoholic patients Psychoneuroendocrinology. 18: 475-483. PMID 8265735 DOI: 10.1016/0306-4530(93)90041-I  1
1991 Zeppetelli E, Gobbi G, Janiri L. Neuroendocrine effects of alcoholism and biological markers: HPA, HPGH, and HPT axes | EFFETTI NEUROENDOCRINI DELL'ALCOLISMO E MARKERS BIOLOGICI PUTATIVI: ASSI IPOTALAMO-IPOFISI-SURRENE (HPA), IPOTALAMO-IPOFISI-GH (HPGH), IPOTALAMO-IPOFISI-TIROIDE (HPT) Rivista Di Neurobiologia. 37: 41-61.  1
Show low-probability matches.